196 related articles for article (PubMed ID: 33578599)
1. PRRX1 promotes lymph node metastasis of gastric cancer by regulating epithelial-mesenchymal transition.
Yao J; Zhang Y; Xia Y; Zhu C; Wen X; Liu T; Da M
Medicine (Baltimore); 2021 Feb; 100(6):e24674. PubMed ID: 33578599
[TBL] [Abstract][Full Text] [Related]
2. Relationship between PRRX1, circulating tumor cells, and clinicopathological parameter in patients with gastric cancer.
Zhang Y; Yao J; Feng J; Wang S; Yang Z; Huang W; Da M
J BUON; 2020; 25(3):1455-1462. PubMed ID: 32862590
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of paired- related homeobox 1 and Smad2 in gastric cancer.
Yang Z; Huang WX; Wang S; Yao JB; Da M
Eur J Cancer Prev; 2021 Mar; 30(2):154-160. PubMed ID: 32868636
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer.
Okubo K; Uenosono Y; Arigami T; Yanagita S; Matsushita D; Kijima T; Amatatsu M; Uchikado Y; Kijima Y; Maemura K; Natsugoe S
Gastric Cancer; 2017 Sep; 20(5):802-810. PubMed ID: 28247164
[TBL] [Abstract][Full Text] [Related]
5. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
[TBL] [Abstract][Full Text] [Related]
6. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
7. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
8. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
9. ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells.
Dai YH; Tang YP; Zhu HY; Lv L; Chu Y; Zhou YQ; Huo JR
Dig Dis Sci; 2012 May; 57(5):1253-60. PubMed ID: 22350782
[TBL] [Abstract][Full Text] [Related]
10. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer.
Lee HH; Lee SH; Song KY; Na SJ; O JH; Park JM; Jung ES; Choi MG; Park CH
BMC Cancer; 2017 Oct; 17(1):670. PubMed ID: 28974196
[TBL] [Abstract][Full Text] [Related]
12. miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
Lv ZD; Kong B; Liu XP; Jin LY; Dong Q; Li FN; Wang HB
J Cell Mol Med; 2016 May; 20(5):864-73. PubMed ID: 26820102
[TBL] [Abstract][Full Text] [Related]
13. PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer.
Guo J; Fu Z; Wei J; Lu W; Feng J; Zhang S
Med Oncol; 2015 Jan; 32(1):393. PubMed ID: 25428393
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of vimentin-expressing gastric cancer cells in bone marrow.
Iwatsuki M; Mimori K; Fukagawa T; Ishii H; Yokobori T; Sasako M; Baba H; Mori M
Ann Surg Oncol; 2010 Sep; 17(9):2526-33. PubMed ID: 20358301
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of vasculogenic mimicry, PRRX1, and CIP2A in clear cell renal cell carcinoma and its clinicopathological significance.
Wang X; Yang R; Wang Q; Wang Y; Ci H; Wu S
Medicine (Baltimore); 2019 Sep; 98(36):e17028. PubMed ID: 31490389
[TBL] [Abstract][Full Text] [Related]
16. Low PRRX1 expression and high ZEB1 expression are significantly correlated with epithelial-mesenchymal transition and tumor angiogenesis in non-small cell lung cancer.
Yang R; Liu Y; Wang Y; Wang X; Ci H; Song C; Wu S
Medicine (Baltimore); 2021 Jan; 100(4):e24472. PubMed ID: 33530259
[TBL] [Abstract][Full Text] [Related]
17. Bapx1 mediates transforming growth factor-β- induced epithelial-mesenchymal transition and promotes a malignancy phenotype of gastric cancer cells.
Ouyang S; Zhu G; Ouyang L; Luo Y; Zhou R; Pan C; Bin J; Liao Y; Liao W
Biochem Biophys Res Commun; 2017 Apr; 486(2):285-292. PubMed ID: 28315334
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients.
Hou F; Yuan W; Huang J; Qian L; Chen Z; Ge J; Wu S; Chen J; Wang J; Chen Z
Med Oncol; 2012 Dec; 29(4):2691-700. PubMed ID: 22189617
[TBL] [Abstract][Full Text] [Related]
20. Downregulated vimentin and upregulated E-cadherin in T1 stage non-small-cell lung cancer: does it suggest a mesenchymal-epithelial transition?
Luo T; Wang L; Wu P; Gong W; Chen W; Zhao H; Zheng Z
Neoplasma; 2017; 64(5):693-699. PubMed ID: 28592120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]